Prestige Consumer Healthcare Inc. Stock
Prestige Consumer Healthcare Inc. shows a slight decrease today, losing -€0.500 (-0.870%) compared to yesterday.
Our community is currently high on Prestige Consumer Healthcare Inc. with 3 Buy predictions and 0 Sell predictions.
As a result the target price of 64 € shows a slightly positive potential of 12.28% compared to the current price of 57.0 € for Prestige Consumer Healthcare Inc..
Pros and Cons of Prestige Consumer Healthcare Inc. in the next few years
Pros
?
B****
?
M***** P*******
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Prestige Consumer Healthcare Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Prestige Consumer Healthcare Inc. | -0.870% | 0.000% | 4.545% | -26.282% | 7.477% | 0.877% | 59.722% |
| Apollo Medical Holdings, Inc. | 0.930% | 23.164% | 19.126% | -12.097% | 2.830% | -39.021% | - |
| Petmed Express Inc | 0.720% | -0.382% | -6.820% | -36.845% | -18.572% | -86.329% | -91.699% |
| Suzuken Co Ltd | 0.580% | -1.143% | 1.765% | 38.400% | 5.488% | 38.400% | 10.897% |
Comments
Prestige Consumer Healthcare (NYSE:PBH) had its price target lowered by analysts at Oppenheimer Holdings, Inc. from $82.00 to $72.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare (NYSE:PBH) was upgraded by analysts at Sidoti from a "neutral" rating to a "buy" rating. They now have a $80.00 price target on the stock.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for PBH provided by MarketBeat